S. Röttger, H. Waldmann
FULL PAPER
6.08 (dd, J = 2, 16 Hz, 0.4 H), 5.93 (m, 1 H), 5.34 and 5.26 (m,
each 1 H), 5.05 (s, 0.4 H), 4.66 (dt, J = 1, 6 Hz, 0.8 H), 4.64 (dt, J
= 1, 6 Hz, 1.2 H), 3.64 (s, 1.2 H), 4.40 (s, 1.2 H), 4.35(s, 0.8 H),
tion was achieved by preparative HPLC. Yield: 6.7 mg (0.02 mmol,
28%), colourless oil. H NMR (400 MHz, CDCl3): δ = 7.34 (d, J
1
= 5 Hz, 2 H), 7.24–7.19 (m, 3 H), 5.99–5.82 (m, 1 H), 5.36–5.30
2.45 (s, 1 H) ppm. 13C NMR (125 MHz, CDCl3): δ = 192.0, 172.4, (m, 2 H), 4.72 (d, J = 15 Hz), 3.78–3.56 (m, 2 H), 2.80–2.68 (m, 1
168.9, 167.2, 147.8, 138.4, 131.3, 131.9, 131.8, 118.8, 118.4, 90.9,
H), 2.60–2.45 (m, 2 H), 2.19–2.14 (d, J = 12 Hz, 1 H), 1.98–1.76 (m,
4 H), 1.58–1.44 (m, 3 H) ppm. HRMS [FAB/HR] for C15H20O4, M
= 340.41 g mol–1, calculated: [M + H]+: 341.1755; found 341.1802.
70.6, 67.4, 65.6, 47.0 ppm. IR: ν = 3426 (s, alcohol) cm–1. HRMS
˜
[FAB/LR] for C9H12O4, M = 184.19 g mol–1, calculated: [M + H]+:
185.08; found 185.03.
Allyl rac-2-Acetyl-1,2,3,4,6,7,8,8a-octahydro-4-(hydroxymethyl)-6-
oxoisoquinolin-5-carboxylate (16d): Resin (100 mg) was treated with
N-acetylpiperidone (10 equiv.) as described for compound 16a. IR:
Allyl
6,6-(Ethylenedioxy)-2,3,4,4a,5,6,7,8-octahydro-4-(hydroxy-
methyl)-2-oxonaphthalene-1-carboxylate (16a): A mixture of cyclo-
hexane-1,4-dione monoethylene acetal (0.11 g, 0.7 mmol), pyrroli-
dine (0.29 mL, 3.5 mmol) and toluene (5 mL) was heated at reflux
in a toluene-filled Dean–Stark water separator until the conversion
into the enamine was complete (monitored by GC-MS). The sol-
vent and excess pyrrolidine were removed under reduced pressure,
yielding the pure enamine as a pale yellow oil, which was stored
under argon and dissolved in dry (!) methanol/1,4-dioxane (3:1,
ν = 1739 (s, ester) cm–1.
˜
The crude product was cleaved from solid support by treatment of
the resin with TBAF in THF (1 ) at room temperature overnight.
The resin was again washed twice with THF and the combined
organic phases were washed with saturated NaHCO3 solution and
saturated sodium chloride solution and dried (MgSO4). Purifica-
tion was achieved by preparative HPLC. Yield: 8 mg (0.026 mmol,
1
0.7 mL).
A suspension of polymer-bound alcohol (100 mg,
37%), colourless oil. H NMR (400 MHz, CDCl3): δ = 6.08–5.84
0.7 mmol g–1) in methanol/1,4-dioxane was swollen, after which the
dissolved enamine was added. The suspension was shaken at 50 °C
for 20 h, and, after addition of base (3 equiv.), for an additional
24 h. Afterwards the solution was quenched with water/THF and
the resin was filtered off. It was washed three times each with THF
and CH2Cl2, twice with HCOOH in CH2Cl2 (0.5 , 5 s), five times
with CH2Cl2 and once with MeOH and dried under reduced pres-
(m, 1 H), 5.32 (m, 2 H), 4.74 (d, J = 15 Hz), 3.86 (dq, J = 2, 9 Hz,
1 H), 3.79–3.58 (m, 2 H), 3.21–3.13 (m, 1 H), 2.82–2.59 (m, 2 H),
2.60–2.45 (m, 2 H), 2.10–1.96 (m, 1 H), 2.00–1.72 (m, 3 H) ppm.
HRMS [FAB/HR] for C16H21NO5, M = 307.34 g mol–1, calculated:
[M + H]+: 308.1500; found 308.1524.
Acknowledgments
sure. IR: ν = 1739 (s, ester) cm–1. The crude product was cleaved
˜
from the solid support by treatment of the resin with TBAF in
THF (1 ) at room temperature overnight. The resin was washed
twice with THF and the combined organic phases were washed
with saturated NaHCO3 solution and saturated sodium chloride
solution and dried (MgSO4). Purification was achieved by prepara-
tive HPLC. Yield: 7 mg (0.022 mmol, 31%), colourless oil. 1H
NMR (400 MHz, CDCl3): δ = 6.08–5.84 (m, 1 H), 5.32 (m, 2 H),
4.74 (d, J = 15 Hz), 3.99 (s, 4 H), 3.79–3.58 (m, 2 H), 2.82–2.68
(m, 1 H), 2.60–2.45 (m, 2 H), 2.19–2.14 (d, J = 11 Hz, 1 H), 2.00–
1.72 (m, 3 H), 1.62–1.42 (m, 4 H) ppm. 13C NMR (125 MHz,
CDCl3): δ = 198.4, 166.0, 164.4, 131.6, 118.6, 107.6, 66.5, 64.6,
64.6, 67.1, 38.8, 37.1, 31.3, 29.7, 24.3, 19.9 ppm. HRMS [FAB/HR]
for C17H22O6, M = 322.35 g mol–1, calculated: [M + H]+: 323.1496;
found 323.1510.
This research was supported by the Deutsche Forschungsgemein-
schaft, the Max-Planck-Gesellschaft and the Fonds der Chem-
ischen Industrie.
[1] a) R. Breinbauer, I. Vetter, H. Waldmann, Angew. Chem. Int.
Ed. 2002, 41, 2878–2890; b) M. A. Koch, L.-O. Wittenberg, S.
Basu, D. A. Jeyaraj, E. Gourzoulidou, K. Reinecke, A. Oderm-
att, H. Waldmann, Proc. Natl. Acad. Sci. 2004, 101, 16721–
16726; c) M. A. Koch, H. Waldmann, Drug Discovery Today
2005, 10, 471–483.
[2] For recent reviews of natural product-guided compound collec-
tions see: a) P. Arya, R. Joseph, Z. Gan, B. Rakic, Chem. Biol.
2005, 12, 163–180; b) R. Balamurugan, F. J. Dekker, H. Wald-
mann, Molecular BioSystems 2005, 1, 36–45.
[3] a) B. C. Shook, F. F. Fleming, T. Jiang, O. W. Steward, Tetrahe-
dron 2003, 59, 737–745; b) J. R. Hanson, Nat. Prod. Rep. 2001,
18, 88–94; c) R. A. Hill, J. D. Connolly, Nat. Prod. Rep. 2001,
18, 131–147.
[4] a) R. E. Conrow, J. A. Marshall, J. Am. Chem. Soc. 1983, 105,
5679–5688; b) L. Kissau, P. Stahl, R. Mazitschek, A. Giannis,
H. Waldmann, J. Med. Chem. 2003, 46, 2917–2931; c) P. Kraft,
J. A. Bajgrowicz, C. Denis, G. Frater, Angew. Chem. Int. Ed.
2000, 39, 2980–3010; d) J. L. Blanchard, R. E. Cebula, M. D.
Boisclair, K. Pal, N. J. Bockovich, Bioorg. Med. Chem. Lett.
1997, 7, 2015–2020.
[5] For the synthesis of a natural product-derived decalin collec-
tion on solid support see: D. Brohm, N. Phillipe, S. Metzger,
A. Bhargava, O. Müller, F. Lieb, H. Waldmann, J. Am. Chem.
Soc. 2002, 124, 13171–13178.
[6] a) M. E. Jung, Tetrahedron 1976, 32, 3–31; b) R. E. Gawley,
Synthesis 1976, 777–794.
[7] a) S. I. Zavylov, I. N. Nazarov, Zh. Obshch. Khim. Engl. Transl.
1953, 23, 1793–1794; b) J. M. Streiber, R. Zibuck, Org. Synth.
1993, 71, 236–241.
16b: Resin (100 mg) was treated with p-methylcyclohexanone
(10 equiv.) as described for compound 16a. IR: ν = 1716 (s, es-
˜
ter) cm–1. The crude product was cleaved from solid support by
treatment of the resin with TBAF in THF (1 ) at room tempera-
ture overnight. The resin was again washed twice with THF and
the combined organic phases were washed with saturated NaHCO3
solution and saturated sodium chloride solution and dried
(MgSO4). Purification was achieved by preparative HPLC. Yield:
6.2 mg (0.0224 mmol, 32%), colourless oil. 1H NMR (400 MHz,
CDCl3): δ = 6.08–5.82 (m, 1 H), 5.34–5.28 (m, 2 H), 4.74 (d, J =
15 Hz), 3.78–3.56 (m, 2 H), 2.82–2.68 (m, 1 H), 2.60–2.45 (m, 2
H), 2.19–2.14 (d, J = 12 Hz, 1 H), 1.98–1.76 (m, 4 H), 1.58–1.44
(m, 3 H), 0.82 (s, 3 H) ppm. HRMS [FAB/HR] for C16H22O4, M
= 278.34 g mol–1, calculated: [M + H]+: 279.1598; found 279.1613.
16c: Resin (100 mg) was treated with p-phenylcyclohexanone
(10 equiv.) as described for compound 16a. IR: ν = 1739 (s, es-
˜
ter) cm–1.
[8] C. A. Verbricky, W. S. McDonald, C. K. Zercher, J. Org. Chem.
1997, 62, 1215–1222.
[9] a) F. Xie, S. Hanessian, Tetrahedron Lett. 1998, 39, 737–740;
b) F. Xie, S. Hanessian, Tetrahedron Lett. 1998, 39, 733–736.
[10] M. F. Gordeev, G. W. Luehr, C. H. Hui, E. M. Gordon, D. V.
Patei, Tetrahedron 1998, 54, 15879–15890.
The crude product was cleaved from solid support by treatment of
the resin with TBAF in THF (1 ) at room temperature overnight.
The resin was again washed twice with THF and the combined
organic phases were washed with saturated NaHCO3 solution and
saturated sodium chloride solution and dried (MgSO4). Purifica-
2098
www.eurjoc.org
© 2006 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2006, 2093–2099